DIFFERENTIAL-EFFECTS OF SCOPOLAMINE AND MECAMYLAMINE ON WORKING AND REFERENCE MEMORY IN THE RAT

被引:54
作者
MORAN, PM
机构
[1] Marion Merrell Dow Research Institute, 67009 Strasbourg Cedex, 16, rue d'Ankara
关键词
SCOPOLAMINE; MECAMYLAMINE; T-MAZE ALTERNATION; T-MAZE DISCRIMINATION; MUSCARINIC; NICOTINIC; MEMORY; RAT;
D O I
10.1016/0091-3057(93)90502-K
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The effects of the muscarinic antagonist scopolamine (0.1-0.6 mg/kg, IP) and the nicotinic antagonist mecamylamine (1-10 mg/kg) were compared in T-maze alternation and discrimination tasks in the rat. Scopolamine dose dependently disrupted performance on the alternation task and potentiated the increase in errors made in controls when the delay between forced and choice runs was increased from 0 to 30 s. Mecamylamine disrupted performance at the 10-mg/kg dose only and dose dependently inhibited the increase in errors made in controls when the delay between forced and choice runs was increased to 30 s. In simple T-maze discrimination, only the 0.6-mg/kg dose of scopolamine disrupted performance of the task, while mecamylamine at both 5 and 10 mg/kg disrupted task performance. These results confirm that working memory tasks are more sensitive to central muscarinic blockade than reference memory tasks. They also demonstrate that in delay conditions working memory performance is enhanced following central nicotinic blockade while reference memory performance is disrupted. This suggests that centrally active muscarinic and nicotinic antagonists have dissociable effects on memory processes in the rat.
引用
收藏
页码:533 / 538
页数:6
相关论文
共 48 条
[1]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[2]  
BEATTY WW, 1985, PHYSL PSYCHOL, V4, P82
[3]   EFFECTS OF SCOPOLAMINE AND UNILATERAL LESIONS OF THE BASAL FOREBRAIN ON T-MAZE SPATIAL DISCRIMINATION AND ALTERNATION IN RATS [J].
BENINGER, RJ ;
JHAMANDAS, K ;
BOEGMAN, RJ ;
ELDEFRAWY, SR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (05) :1353-1360
[4]  
BOHDANECKY Z., 1967, INT J NEUROPHARMACOL, V6, P217
[5]   BENEFICIAL-EFFECTS OF NICOTINE ADMINISTERED PRIOR TO A DELAYED MATCHING-TO-SAMPLE TASK IN YOUNG AND AGED MONKEYS [J].
BUCCAFUSCO, JJ ;
JACKSON, WJ .
NEUROBIOLOGY OF AGING, 1991, 12 (03) :233-238
[6]   QUALITATIVE-ANALYSIS OF SCOPOLAMINE-INDUCED AMNESIA [J].
CAINE, ED ;
WEINGARTNER, H ;
LUDLOW, CL ;
CUDAHY, EA ;
WEHRY, S .
PSYCHOPHARMACOLOGY, 1981, 74 (01) :74-80
[7]  
CHIAPETTA L, 1969, ARCH INT PHARMACOD T, V79, P161
[8]   DOPAMINERGIC MECHANISMS IN THE LOCOMOTOR STIMULANT EFFECTS OF NICOTINE [J].
CLARKE, PBS .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1427-1432
[9]   REINFORCED ALTERNATION PERFORMANCE IS IMPAIRED BY MUSCARINIC BUT NOT BY NICOTINIC RECEPTOR BLOCKADE IN RATS [J].
CLARKE, PBS ;
FIBIGER, HC .
BEHAVIOURAL BRAIN RESEARCH, 1990, 36 (03) :203-207
[10]   CAUDATE-NUCLEUS AND MEMORY FOR EGOCENTRIC LOCALIZATION [J].
COOK, D ;
KESNER, RP .
BEHAVIORAL AND NEURAL BIOLOGY, 1988, 49 (03) :332-343